N- (5- (cis- 3,5- dimethyl- 1- piperazinyl)- 2- (methyloxy) phenyl)- 3- fluoro- 4- (5- methyl- 2- furanyl)benzenesulfonamide

an oral centrally acting ghrelin receptor agonist

Also Known As:

GSK894281; N-(5-(cis-3,5-dimethyl-1-piperazinyl)-2-(methyloxy) phenyl)-3-fluoro-4-(5-methyl-2-furanyl)benzenesulphonamide

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Necrosis 03/01/2015 - "Using a ghrelin receptor agonist (GSK894281), a compound that produces myocardial degeneration/necrosis in rats after 28 days at doses of 0.3, 1, 10, or 60 mg/kg/d, we dosed rats across a range of similar doses (0, 0.3, 60, or 150 mg/kg/d) for 7 days to determine whether CV toxicity could be detected in a shorter study. "

1.	Ghrelin Receptors